Physician profile
Amanda Roy
NPI 1548987696
$1,214.60
in general payments reported to CMS, 2019-2025
15 companies · $468 in 2025
The $468 reported for 2025 was more than what 85% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $87.10 · 2023: $455 · 2024: $204 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $228.05 | 2022-2025 | |
| Organon LLC | $212.84 | 2022-2025 | Nexplanon, Vtama |
| Mayne Pharma Commercial LLC | $198.17 | 2022-2025 | |
| Myriad Women'S Health, INC. | $177.97 | 2023 | Myrisk |
| Exeltis, USA INC. | $70.19 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $63.65 | 2023-2025 | Veozah |
| Abbvie INC. | $53.96 | 2023-2025 | |
| Exact Sciences Corporation | $48.07 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sage Therapeutics, LLC | $36.72 | 2024-2025 | Zurzuvae |
| Medicem INC. | $32.00 | 2023 | |
| Shield Therapeutics INC | $23.56 | 2024 | |
| Sumitomo Pharma America, INC. | $20.19 | 2025 | Gemtesa |
| Myovant Sciences INC. | $17.88 | 2022 | |
| Hologic Sales and Service, LLC | $15.93 | 2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Pfizer INC. | $15.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.